Expert to focus on the wonder of hormones that control energy balance and metabolism

An exploration of the beauty and wonder of the hormones that control our energy balance and metabolism and how they can be replaced and manipulated to improve human health will be the focus of a lecture celebrating the centenary of insulin by Professor Sir Stephen O'Rahilly at the Royal Society of Medicine on Thursday 2 December 2021.

One of the UK's most distinguished endocrinologists, Professor O'Rahilly is Director of the MRC Metabolic Diseases Unit at the University of Cambridge and earlier this year became an Honorary Fellow of the Royal Society of Medicine.

The evening will begin with a welcome and introduction by Professor of Nephrology and former Physician to HM The Queen, Professor Sir John Cunningham.

Mr Chris Askew OBE, Chief Executive of Diabetes UK, who will also be speaking during the evening, said: "Sir Stephen follows in the footsteps of the doctors and scientists whose discovery of insulin was one of the greatest medical breakthroughs in history, going on to save millions of lives around the world. Since 1934, Diabetes UK has been working tirelessly with scientists, sharing knowledge and taking on diabetes together, but there is so much more to be done. Diabetes UK is committed to funding research, breaking new ground, and leading the fight to eventually achieve a world where diabetes can do no harm."

The Royal Society of Medicine plays an important role in sharing scientific understanding of conditions such as diabetes, which affects so many families in the UK and across the globe. We are delighted that our Honorary Fellow, Professor Sir Stephen O'Rahilly, will be enlightening our audience at this public lecture with his unique perspective on the world of human metabolic science."

Ms Michele Acton, Chief Executive, Royal Society of Medicine


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
New therapeutic approach offers hope to treat obesity and related metabolic disorders